— The Kroger Co. (NYSE: KR) reported its third-quarter 2019 adjusted earnings of $0.47 per share versus $0.49 per share expected.
— Net sales rose by 0.7% to $28 billion versus $28.18 billion expected. Excluding fuel and dispositions, sales grew 2.7%. Identical Sales without fuel grew 2.5% and digital sales grew 21%.
— The FIFO gross margin rate, excluding fuel, a decrease of 24 basis points was primarily driven by industry-wide lower gross margin rates in pharmacy and continued growth in the specialty pharmacy business.
— Looking ahead into fiscal 2019, the company lowered its GAAP EPS guidance to the range of $2.17-2.27 from the previous range of $2.30-2.40.
— Adjusted EPS is still expected to be in the range of $2.15-2.25 for fiscal 2019. This is compared to the consensus estimates of $2.20.
— Operating profit outlook is lowered to the range of $2.4-2.5 billion from the prior range of $2.8-2.9 billion while adjusted operating profit is still predicted to be $2.9-3 billion for the full year.
— Capital expenditures are still anticipated to be in the range of $3-3.2 billion for fiscal 2019.
— For fiscal 2020, the company predicts an adjusted EPS of $2.30-2.40. This is compared to the consensus estimates of $2.33.
Most Popular
Broadcom (AVGO) thrives on growing AI business. Is the stock a buy?
Broadcom, Inc. (NASDAQ: AVGO), a leading provider of semiconductor solutions for wired and wireless communications, recently impressed the market with upbeat financial outlook highlighting strong prospects for its AI business
After a weak first half, will NIKE (NKE) hit the recovery path this year?
After a prolonged slowdown, NIKE, Inc. (NYSE: NKE) is working on a turnaround plan to regain the brand’s strength. In recent years, the sneaker giant’s overall performance has not been
Lennar (LEN): Even the best-laid plans can go wrong
Shares of Lennar Corporation (NYSE: LEN) stayed green on Monday. The stock has dropped 25% over the past three months. The homebuilder delivered underwhelming results for the fourth quarter of
Comments
Comments are closed.